xslot88.kg.co

xslot88.kg.co Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 in ASML To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in ASML between January 24, 2024 and October 15, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . [You may also click here for additional information] NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP , a leading national securities law firm, is investigating potential claims against ASML Holding N.V. ("ASML" or the "Company") ASML and reminds investors of the January 13, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com . As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the issues being faced by suppliers, like ASML, in the semiconductor industry were much more severe than Defendants had indicated to investors; (2) the pace of recovery of sales in the semiconductor industry was much slower than Defendants had publicly acknowledged; (3) Defendants had created the false impression that they possessed reliable information pertaining to customer demand and anticipated growth, while also downplaying risk from macroeconomic and industry fluctuations, as well as stronger regulations restricting the export of semiconductor technology, including the products that ASML sells; and (4) as a result, Defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis. On October 15, 2024, ASML published earnings for the third quarter of 2024, revealing quarterly bookings of €2.63 billion, a decline of 53% quarter-over-quarter. The Company also announced it expects full year 2025 total net sales to be between €30 billion and €35 billion, with a gross margin between 51% and 53%. On this news, ASML's stock price fell $141.84, or 16.26%, to close $730.43 per share on October 15, 2024, thereby injuring investors. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding ASML's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the ASML class action, go to www.faruqilaw.com/ASML or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . Follow us for updates on LinkedIn , on X , or on Facebook . Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d1c9b98d-c31a-4ede-9848-a13838cd5510 © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Kyrie Irving scored 20 points, Daniel Gafford added 16 and the Dallas Mavericks won their first game since star Luka Doncic was injured, beating the Phoenix Suns 98-89 on Friday night. Kevin Durant scored 35 points for the Suns, who have lost four of their past five games. Doncic is expected to miss about a month with a calf injury suffered in the team’s Christmas Day loss to Minnesota. The Mavs were left further short-handed on Friday in the third quarter after forwards Naji Marshall and P.J. Washington — along with Phoenix's Jusuf Nurkic — were ejected after a brief fight. The Mavs persevered anyway thanks to a balanced effort on both ends of the floor. Dallas never trailed and led by as many as 18. Spencer Dinwiddie and Maxi Kleber each scored 15 points and Klay Thompson added 11. Dallas took a 55-39 lead by halftime, led by Irving's 15 points. The Suns shot just 33.3% over the first two quarters. Takeaways Mavericks: It was a gritty win for the Mavs, who controlled the game from the outset despite playing without Doncic. Irving made just 6 of 21 shots overall, but 5 of 10 from behind the arc. Suns: Two days after a galvanizing win on Christmas Day over the Nuggets, the Suns went right back to mediocrity. Part of the problem is the absence of injured All-Star Devin Booker, but as the Mavericks showed on Friday, teams can still have a level of success without one of their stars. Key moment The Suns briefly cut the Mavs advantage to 81-75 midway through the fourth, but Dallas' Quentin Grimes responded with a tough 3-pointer to push the lead back to nine. Key stat The Suns have a 7-14 record since starting the season at 8-1. Up next Mavericks at Trail Blazers on Saturday; Suns at Warriors on Saturday‘Chosen chaos’: Detested Macron goes on attack after government collapse

1 Magnificent Canadian Dividend Stock Down 13% to Buy and Hold Forever4A All-Idaho boys soccer team: The state’s top players from its deepest division

None

The Australian share market may be at record highs right now, but that doesn't mean there aren't ASX 200 shares out there with the potential to generate big returns for investors. For example, the two ASX shares listed below have been named as buys and tipped to rise between 23% and almost 30% over the next 12 months. Here's what analysts are saying about them: ( ) This drinks giant's shares could be dirt cheap according to analysts at Goldman Sachs. The broker currently has a buy rating and $5.50 price target on the ASX 200 share, which implies potential upside of 27% for investors over the next 12 months. And if you include forecast , the total potential 12-month return from Endeavour's shares stretches beyond 31%. Goldman Sachs feels that its shares are simply too cheap given the quality of the company. It recently said: Net net, we reiterate Buy on our continued believe in a high quality retailer gaining share amid a category down-cycle with a resilient growth option in Hotels. Company is trading at FY25 P/E of 17x vs historical average of 22x and WOW 22x, COL 21x. ( ) The team at Bell Potter sees significant upside from this retail giant's shares over the next 12 months. A recent note reveals that its analysts have initiated coverage on the ASX 200 share with a buy rating and $5.80 price target. Based on its current share price of $4.72, this implies potential upside of 23% for investors. In addition, Bell Potter highlights that a 5.4% dividend yield is expected in FY 2025, which boosts the total potential return beyond 28%. The broker recently highlighted Harvey Norman's exposure to artificial intelligence (AI) as a reason to be positive. It said: We initiate coverage with a Buy rating and PT of $5.80 based on a based on a sum-ofthe-part valuation with the overall business operations on a DCF (WACC ~10%, TGR ~3%) methodology and the property bank on a fair value basis (as last reported) assuming largely similar capitalisation rates over FY25e. Similar to JBH, we see a sizable upside from the AI driven upgrade cycle to Consumer Electronics sales at HVN which we size at up to ~12% of Australian sales given the position of the company as one of the leading players with large format stores globally which are considered attractive to global technology brands/suppliers when releasing new products.

OAP, 95, was forced to wait on pavement with broken hip for hours after being told by NHS staff she’s ‘not a priority’